EGFR and non-small cell lung carcinoma: Radiation toxicities of Grade 3 were observed in approximately 10% of patients, analogous to that of synchronous/concurrent chemoradiotherapy36, 48, 51 or EGFR‐TKIs with radiotherapy52, 53 in stage IV NSCLC without MPE.